Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
Lyophilized from 0.22 um filtered solution in PBS, pH 7.4 , Contact us for customized product form or formulation.
Formulierung:
Lyophilized
Target-Kategorie:
S
Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Immobilized Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM at 2 ug/mL (100 uL/well) can bind SARS-CoV-2 S protein RBD, His Tag with a linear range of 0.6-2.4 ng/mL (QC tested).
Serial dilutions of Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM was detected by Biotinylated Human ACE2, His,Avitag with a half maximal inhibitory concentration (IC50) of 0.88 ug/mL (Routinely tested).
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten